| 000 | 01679 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515020109.0 | ||
| 264 | 0 | _c20061121 | |
| 008 | 200611s 0 0 eng d | ||
| 022 | _a1470-269X | ||
| 024 | 7 |
_a10.1038/sj.tpj.6500376 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurckart, G J | |
| 245 | 0 | 0 |
_aPharmacogenomics and lung transplantation: clinical implications. _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _c |
||
| 300 |
_a301-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 1 |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 |
_aGraft Rejection _xblood |
| 650 | 0 | 4 | _aHeart Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aLung Transplantation |
| 650 | 0 | 4 |
_aOrganic Anion Transporters _xgenetics |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHutchinson, I V | |
| 700 | 1 | _aZeevi, A | |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 6 _gno. 5 _gp. 301-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.tpj.6500376 _zAvailable from publisher's website |
| 999 |
_c16130547 _d16130547 |
||